Product Program year 2025 Source: CMS Open Payments

Torus Stent Graft System

Device Cardiology/Vascular Diseases

PDI 00860008946416

Open in the dashboard

General payments

$1,151,224

5,224 payments

Research payments

$481,465

287 payments

Through program year 2025, $1,151,224 in general payments and $481,465 in research payments were reported against Torus Stent Graft System (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $681,443 2,641
2025 Research $7,628 6
2024 General $362,789 2,063
2024 Research $125,289 83
2023 General $106,992 520
2023 Research $348,548 198

Breakdown

Who paid General payments · program years 2023–2025
  1. Endologix, Inc. $1,151,224 5,224 payments
Top recipients General payments · program year 2025
  1. John Park Vascular Surgery · Omaha, NE $71,754 11% · 55 payments
  2. Venkatesh Ramaiah Vascular Surgery · Scottsdale, AZ $47,268 7% · 62 payments
  3. James Joye Interventional Cardiology · Mountain View, CA $34,277 5% · 40 payments
  4. Christopher Busken Vascular Surgery · Live Oak, TX $31,840 5% · 58 payments
  5. Jaafer Golzar Interventional Cardiology · Oak Lawn, IL $27,564 4% · 34 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $392,178 58% · 514 practitioners
  2. Interventional Cardiology Internal Medicine $137,235 20% · 185 practitioners
  3. Cardiovascular Disease Internal Medicine $44,615 7% · 103 practitioners
  4. Surgery $35,040 5% · 41 practitioners
  5. Vascular & Interventional Radiology Radiology $16,911 3% · 44 practitioners

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $80,669 12% · 140 recipients
  2. Nebraska $72,888 11% · 3 recipients
  3. Arizona $63,573 9% · 32 recipients
  4. Texas $61,855 9% · 202 recipients
  5. California $60,658 9% · 86 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,224 general · 287 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record